BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9467803)

  • 1. Use of quantitative urinalysis in monitoring cocaine use.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    NIDA Res Monogr; 1997; 175():253-64. PubMed ID: 9467803
    [No Abstract]   [Full Text] [Related]  

  • 2. Is quantitative urinalysis more sensitive?
    Li SH; Chiang N; Tai B; Marschke CK; Hawks RL
    NIDA Res Monogr; 1997; 175():265-86. PubMed ID: 9467804
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.
    Jones RT
    NIDA Res Monogr; 1997; 175():221-34. PubMed ID: 9467801
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative urine levels of cocaine and other substances of abuse.
    Wilkins JN
    NIDA Res Monogr; 1997; 175():235-52. PubMed ID: 9467802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative versus qualitative urinalysis for benzoylecgonine in clinical trials for the assessment of cocaine use.
    Li SH; Chiang CN; Tai BC; Marschke CK; Hawks RL
    Psychopharmacol Bull; 1995; 31(4):671-9. PubMed ID: 8851639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement properties of quantitative urine benzoylecgonine in clinical trials research.
    Delucchi KL; Jones RT; Batki SL
    Addiction; 1997 Mar; 92(3):297-302. PubMed ID: 9219391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cocaine use with quantitative urinalysis and estimation of new uses.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    Addiction; 1997 Jun; 92(6):717-27. PubMed ID: 9246799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine testing for drug use among male arrestees--United States, 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Nov; 38(45):780-3. PubMed ID: 2509890
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of reported drug use and urinalysis in the assessment of drug use.
    Jain R; Tripathi BM; Singh R
    Natl Med J India; 2001; 14(5):315-6. PubMed ID: 11767230
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use and abuse of substance abuse analyses in urine].
    Lafolie P; Beck O; Boréus L; Hjemdahl P; Borg S; Rydberg U
    Lakartidningen; 1991 Oct; 88(40):3290-4. PubMed ID: 1943342
    [No Abstract]   [Full Text] [Related]  

  • 12. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative urine screening for the diagnosis and treatment of cocaine abuse.
    Tennant F
    NIDA Res Monogr; 1989; 95():318-9. PubMed ID: 2701298
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
    Buchan BJ; Walsh JM; Leaverton PE
    J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 17. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput urinalysis of abused drugs based on a SPE-LC-MS/MS method coupled with an in-house developed post-analysis data treatment system.
    Cheng WC; Yau TS; Wong MK; Chan LP; Mok VK
    Forensic Sci Int; 2006 Oct; 162(1-3):95-107. PubMed ID: 16876358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine testing during treatment of cocaine dependence.
    Burke WM; Ravi NV; Dhopesh V; Vandegrift B; Maany I; McLellan AT
    NIDA Res Monogr; 1989; 95():320-1. PubMed ID: 2701299
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
    Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
    Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.